bioRxivMicrobiology
Detection and phenotypic characterization of carbapenem non susceptible gram-negative bacilli isolated from clinical specimens
A. Abdeta, A. Bitew, S. Fentaw, E. Tsige, D. Assefa, T. Lejisa, Y. Kefyalew, E. Tigabu
Abstract
BackgroundMulti-drug resistant, extremely drug-resistant, pan-drug resistant, carbapenem-resistant, and carbapenemase-producing gram-negative bacteria are becoming more common in health care settings and are posing a growing threat to public health. ObjectiveThe study was aimed to detect and phenotypically characterize carbapenem non susceptible gram-negative bacilli at Ethiopian Public Health Institute. Materials and methodsProspective cross-sectional study was conducted from June 30, 2019, to May 30, 2020, at the national reference laboratory of the Ethiopian Public Health Institute. Clinical samples were collected, inoculated, and incubated in accordance to standard protocol for each sample. Antimicrobial susceptibility testing was done using Kirby Bauer disk diffusion. Identification was done using the traditional biochemical method. Multidrug-resistant and extensively drug-resistant were classified using a standardized definition established by European Centers for Disease prevention and control and the United States Centers for Disease prevention and control experts. Carbapenemase production was confirmed by modified carbapenem inactivation and a simplified carbapenem inactivation method. Meropenem with EDTA was used to differentiate serine carbapenemase and Metallo {beta}-lactamase. ResultsA total of 1337 clinical specimens were analyzed, of which 429-gram negative bacilli isolates were recovered. Out of 429 isolates 319, 74, and 36 were Enterobacterales, Acinetobacter species, and P. aeruginosa respectively. In our study, the prevalence of Multidrug-resistant, extensively drug-resistant, Carbapenemase-producing, and carbapenem non-susceptible Gram-negative bacilli were, 45.2%, 7.7%, 5.4%, and 15.4% respectively. Out of 66 isolates screened for Carbapenemase, 34.8% (23/66) were Carbapenemase enzyme producers. Ten out of twenty-three Carbapenemase-positive organisms were Metallo-beta-lactamase producers. Thirteen out of twenty-three isolates were serine carbapenemase producers. Three out of 13 serine Carbapenemase positive organisms were Klebsiella pneumoniae Carbapenemase. ConclusionThe finding from this study revealed a high prevalence of Multidrug-resistant, extremely drug-resistant, carbapenemase-producing gram-negative bacteria, particularly among Intensive care unit patients at the health facility level, this necessitates a robust laboratory-based antimicrobial resistance monitoring and infection prevention and control program.
- assay: clinical cohort / trial
- research focus: host-pathogen & immune response
- approach: experimental assay
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Detection of NDM-1, VIM-1 and AIM-type Metallo-beta-lactamase genes in Gram-negative bacteria isolated from clinical samples in Tamil Nadu
P. Manohar, A. Joseph, … N. Ramesh·bioRxiv·Nov 29, 2020
- Menace to the ultimate antimicrobials among common Enterobacteriaceae clinical isolates in part of North-East India
- Dissemination of carbapenem-resistance and plasmids encoding carbapenemases in Gram-negative bacteria isolated from India
P. Manohar, S. Leptihn, … R. Nachimuthu·bioRxiv·May 18, 2020
- Expanding Threat of Carbapenemase-Producing Escherichia coli and Klebsiella pneumoniae in Peru: Genomic and Phenotypic Evidence of High-Risk Clones Dissemination
Arturo O. Gonzales-Rodríguez, Roky G. Champi-Merino, … Escobar Valdiviezo Alejandra·bioRxiv·May 1, 2026
- Massive culture-based approach for the screening of AmpC-, ESBL- and carbapenemase producers from complex samples
Gabriel Taddeucci-Rocha, Victoria de Oliveira Costa, … Renata Cristina Picão·bioRxiv·Jan 6, 2025
- A highly multiplexed melt-curve assay for detecting the most prevalent carbapenemase, ESBL and AmpC genes
T. Edwards, C. Williams, … E. Adams·bioRxiv·Nov 15, 2019